samedan logo
 
 
 
spacer
home > pmps > summer 2007 > drug packaging – the prescription for success
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Drug Packaging – The Prescription for Success

Tassilo Korab at the Healthcare Compliance Packaging Council of Europe (HCPC Europe)

Do you know this feeling? You are about to leave your home, you are in a hurry and all of a sudden there are those nagging doubts about whether or not you have taken your medication this morning. You go back to the bathroom, but checking the pack with the medication doesn’t help. There is nothing that indicates whether you have taken your daily dose, and since you don’t want to risk an overdose, you shut the medicine cupboard and leave home, taking your doubts and concerns with you.

People who have to follow a medicinal regimen often have this experience. In addition, the number of medications people have to take often increases with age, as does the risk of non-adherence to the regimen. Many of these people are not really ‘patients’ at all. They don’t suffer in any way, but they most likely will at a later date if their condition remains untreated. They may, for example, have been diagnosed with high blood pressure or an increased level of cholesterol.

In some cases, medicinal treatment will not be able to remove the cause of the condition but will control it to such a level that a good quality of life with little or no restraints can be enjoyed. Such treatment, called secondary prevention, is an essential part of healthcare and is a key element in the cost effectiveness of healthcare expenditure. Pennies not spent on prudent secondary prevention may cost many pounds at a later date.

Clinical trials and data ascertained about the human body’s reaction to modern medicines provide proof of the importance of patient compliance. The introduction of antibiotics highlighted the dangers of non-compliance more than any drug in the past. The consequences were looked at, widening the scope of the investigations from just the failure of the treatment to the causes, the forms and the cost of non-compliance, as well as its impact on public health.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
spacer
Tassilo Korab
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Protagen Protein Services (PPS) expands capabilities for aggregate analytics to include dynamic light scattering (DLS)

Protein aggregation is a common challenge in the manufacturing of biological products. As one of the most sensitive techniques for the detection of aggregates, dynamic light scattering (DLS) provides a simple, fast and non-destructive testing method. An innovative technique based on a unique cuvette layout allows for accurate measurements with as little as a single µL of solution.
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naďve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement